PURGASOL - sennosides docusate sodium tablet 
DLC Laboratories, Inc.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

PURGASOL® Tablets

Drug Facts

Active ingredients
(in each tablet)		Purposes
Docusate sodium 50 mgStool softener
Sennosides 8.6 mgLaxative

Uses

  • relieves occasional constipation (irregularity)
  • generally causes bowel movement in 6-12 hours

Warnings

Do not use

  • this product if you are presently taking mineral oil, unless directed by a doctor
  • laxative products for longer than 1 week unless directed by a doctor

Ask a doctor before use if you have

  • stomach pain
  • nausea
  • vomiting
  • a sudden change in bowel movements that persists over 2 weeks

Stop use and ask a doctor if you have rectal bleeding or fail to have a bowel movement after use of a laxative.These could be signs of a serious condition.

If pregnant or breast-feeding, ask a health professional before use.

KEEP OUT OF REACH OF CHILDREN. In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

  • take preferably at bedtime or as directed by a doctor
age
edad		starting dosage
dosis inicial		maximum dosage
dosis máxima
12 & over
12 y más		2 tablets once a day
2 tabletas una vez al día		4 tablets twice a day
4 tabletas 2 veces al día
6-111 tablet once a day
1 tableta una vez al día		2 tablets twice a day
2 tabletas 2 veces al día
2-5½ tablet once a day
½ tableta una vez al día		1 tablet twice a day
1 tableta 2 veces al día
Under 2
Menor de 2		ask a doctor
consulte con un médico		ask a doctor
consulte con un médico

Other information

  • each tablet contains: calcium 20 mg, sodium 6 mg VERY LOW SODIUM
  • store between 15°-30°C (59°-86°F)

Inactive ingredients

carnauba wax, colloidal silicon dioxide, croscarmellose sodium, dibasic calcium phosphate dihydrate, D&C yellow #10 aluminum lake, FD&C yellow #6 aluminum lake, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, sodium benzoate, stearic acid, titanium dioxide

Questions? ¿Preguntas?

1-800-858-3889

Distributed by / Distribuido por:
DLC Laboratories, Inc.
Paramount, CA 90723 USA

PRINCIPAL DISPLAY PANEL - 60 Tablet Bottle Carton

PURGASOL®
Tablets

VEGETABLE LAXATIVE
AND STOOL SOFTENER
For Relief of Occasional
Constipation

Docusate sodium 50 mg / Sennosides 8.6 mg

SUGAR FREE!

60 Tablets

Gentle
Relief!

Principal Display Panel - 60 Tablet Bottle Carton
PURGASOL 
sennosides docusate sodium tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:24286-1552
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX) SENNOSIDES8.6 mg
DOCUSATE SODIUM (UNII: F05Q2T2JA0) (DOCUSATE - UNII:M7P27195AG) DOCUSATE SODIUM50 mg
Inactive Ingredients
Ingredient NameStrength
CARNAUBA WAX (UNII: R12CBM0EIZ)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
D&C YELLOW NO. 10 (UNII: 35SW5USQ3G)  
DIBASIC CALCIUM PHOSPHATE DIHYDRATE (UNII: O7TSZ97GEP)  
FD&C YELLOW NO. 6 (UNII: H77VEI93A8)  
HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  
SODIUM BENZOATE (UNII: OJ245FE5EU)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
Product Characteristics
Colororange (TCL081) Scoreno score
ShapeROUND (TCL081) Size10mm
FlavorImprint Code TCL081
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:24286-1552-61 in 1 BOX11/16/200910/31/2019
160 in 1 BOTTLE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart33411/16/200910/31/2019
Labeler - DLC Laboratories, Inc. (093351930)

Revised: 9/2020
Document Id: 063fd9a2-5191-42f9-bcce-b8b410366afc
Set id: 388c41ab-8574-408d-80b0-7abc1b3ca630
Version: 5
Effective Time: 20200902
 
DLC Laboratories, Inc.